The AIDS epidemic, although first rec ognized only 20 years ago, has had a profound impact in communities throughout the United States. By mid-2000, more than 750 000 Americans with AIDS had been reported and more than 430 000 Americans had died. 1 After peaking in the mid-1980s, HIV incidence in the United States stabi lized in the late 1980s and early 1990s. 2 The Centers for Disease Control and Prevention (CDC) estimates that the number of new in fections has remained stable at approxi mately 40 000 per year since 1992. 3 An es timated 800 000 to 900 000 Americans were infected with HIV at the end of 1998; of these, as many as 300 000 were unaware of their infection status. 3 Additional approaches are required to break the grip of HIV in the United States. With as many as 5 million people at behav ioral risk for HIV through unsafe sex and drug use, 4 HIV prevention programs have historically been based on behavioral risk factors and demographic characteristics such as race/ethnicity, sex, and age. Activities have been tailored to meet the needs of specific groups without regard to serostatus. Although secondary prevention efforts to reduce asso ciated morbidity and mortality are naturally focused on individuals with HIV, specific primary prevention efforts to reduce transmission from HIV-infected individuals to the uninfected have been limited. The CDC is currently expanding prevention programs to include new and enhanced activities based on HIV serostatus, particularly targeting in dividuals with HIV, as a way to break the current steady state of HIV transmission. (Figure 1 ). SAFE is aimed at those who are infected with HIV-including those cur rently unaware of their serostatus-as well as those who have been tested and found to be uninfected but are at continued high be havioral risk (Table 1) . This commentary pre sents the CDC's strategies for individuals with HIV, which consist of 5 action steps that focus on diagnosing HIV infection in all in fected individuals, linking them to appropri ate high-quality care and prevention serv ices, and supporting them in adhering to treatment regimens and in adopting and sus taining HIV risk reduction behavior. To make the best use of limited resources, such efforts must use accurate surveillance data, includ ing HIV incidence and prevalence; HIV, AIDS, and sexually transmitted disease (STD) case data; and behavioral data to focus care and prevention efforts on the commu nities and localities where HIV transmission is most intense.
Prevention Strategies for Individuals With HIV

Essential Components of SAFE
The 5 SAFE steps are as follows: (1) 
Increase the number of HIV-infected persons who know their serostatus
There are both medical and public health benefits to increasing knowledge of HIV sta tus as early after infection as possible.
Medical benefits of HIV diagnosis. Indi viduals who have early knowledge of their HIV infection can benefit from prophylaxis for op portunistic infections; treatment of STDs, substance abuse, and mental health conditions; ac cess to social services; and, when appropriate, use of combination antiretroviral therapy (ART). 5 Prophylaxis of opportunistic infec tions has been important in reducing HIVrelated morbidity 6 ; treatment of STDs can re duce the risk of HIV transmission; treatment of substance abuse and mental health problems can reduce HIV risk behavior. 7 It is ART, though, that has had the most dramatic effect on morbidity and mortality. HIV-infected in dividuals in care are now living longer than before the advent of highly active antiretroviral agents, 8 and one study suggests that some HIVinfected individuals receiving ART may have a normal life expectancy. 9 AIDS is no longer 1 of the 15 leading causes of death in the United States. 10 Quality of life for individuals with HIV has improved substantially, although the drugs'side effects can be troublesome and even life threatening. Recent information about side effects has resulted in a recommendation to 5 delay the initiation of ART.
Public health benefits of HIV diagnosis.
Although 70% of individuals with HIV remain sexually active after they learn they are in fected, 11, 12 it is clear that when people know they are HIV infected, they are significantly more likely to take steps to protect their part ners than when they were unaware of their in fection. [12] [13] [14] [15] Another important public health reason for considering people with HIV as a priority population for HIV prevention programs is that ART may reduce infectiousness. If low viral load is associated with a lower risk of transmission and if antiretroviral drugs reduce viral load, then antiretroviral drugs may reduce transmission. High plasma viral load is an im portant risk factor for all modes of HIV transmission. [16] [17] [18] [19] [20] [21] [22] In 2 studies in Africa, the risk of heterosexual transmission increased approxi mately 2.5-fold for every 10-fold increase in plasma viral load. 23, 24 Several studies have demonstrated a correlation between plasma HIV RNA and concentration of HIV RNA in semen and cervicovaginal secretions. [25] [26] [27] [28] ART reduces both plasma and genital fluid viral load; persons with the greatest decline in plasma HIV RNA concentration are most likely to show undetectable genital fluid HIV RNA. [26] [27] [28] Although cell-associated virus is frequently present when seminal HIV RNA is undetectable, 29 animal model data suggest that transmission by cell-associated virus may be less efficient than transmission by cell-free virus. 30, 31 The reduction of HIV transmission through the use of antiretroviral treatment is most clearly seen in the reduction of motherto-child transmission. [32] [33] [34] [35] All of these data suggest that ART probably reduces the infec tiousness of HIV during sexual and drug-using exposures, although the evidence is still indi rect. The spread of a sexually transmitted agent in a population is related to the rate of partner change, the agent's transmissibility, and the duration of infectiousness. 36 By lowering viral load, ART can potentially reduce the duration as well as the degree of infectiousness and therefore reduce HIV transmission at the pop ulation level, provided that partner change, condom use, and sexual practices remain un changed.
Because of these individual and public health benefits of HIV diagnoses, the CDC is giving additional emphasis to encouraging those at high risk for infection to seek testing and is expanding access to voluntary testing as a part of SAFE ( Table 2 ). The CDC is piloting a media campaign called "Know Now" to encourage testing through raising individual awareness of the benefits of knowing HIV status among risk populations in high-prevalence, geographically circumscribed areas.This cam paign is using marketing strategies and multi ple forms of media to address motivation for and psychologic barriers to testing. 37 Such media campaigns are also targeting stigma as sociated with testing and a diagnosis of HIV infection.
An important method for making HIV testing more accessible is use of simple, rapid tests. These can be performed without labora- 38 When available in the United States, they will provide oppor tunities to dramatically increase the availabil ity of HIV testing in a variety of settings and thus increase the number of people who know their HIV status. 39 Simple, rapid tests can be used for outreach by community-based or ganizations at social events such as commu nity health fairs or gay pride festivals, or at bars, clubs, or street corners where large num bers of people at risk for HIV infection may congregate. In addition, rapid tests can be used for routine voluntary testing in emergency rooms or other medical settings where HIV prevalence may be elevated. Routinely offering HIV tests to all patients aged 15 to 54 years in high-HIV-prevalence acute care hospital set tings, 40 and in other high-prevalence settings such as drug detoxification units and STD clin ics, should increase the number of people who are aware of their serostatus. Through revised guidelines for HIV counseling and testing, the CDC is encouraging the routine offering of voluntary HIV testing in medical settings where large numbers of HIV-infected people may seek care for non-HIV-related illnesses. 41 Expan sion of voluntary HIV testing is also needed in nonmedical facilities such as correctional institutions where HIV-infected injection drug users are likely to be found.
Increase the use of health care and preventive services
Although three quarters of individuals with HIV seek medical care within 6 months of learning of their HIV infection, 42 some in dividuals, for a variety of personal, social, economic, or other reasons, delay seeking services for up to 5 years. 13, 43 Data are limited on the use of prevention services by individ uals with HIV. Better information is also needed on the performance of current refer ral systems. While the CDC will work with its partners to improve its programs that link people from publicly funded HIV testing set tings to care and prevention services, 44 providers in other settings in which testing occurs will need to develop feasible links to care and prevention service providers. State and local health departments and communitybased organizations can create better links between prevention and care programs, increasing access to both. Case management related to clinical care and social services or prevention case management (case manage ment with risk reduction counseling) 45 can also increase use of both care and prevention services.
Increase high-quality care and treatment
In 1996, one third to two thirds of indi viduals with HIV were not receiving appro priate HIV/AIDS care, either because they were unaware that they were infected with HIV or because care services had not been accessed or delivered. 46 While the Health Resources Ser vices Administration (HRSA) and the Health Care Financing Administration (HCFA) are the leading federal agencies in providing support for HIV care, the CDC will continue to be a part of Public Health Service efforts to con tinually update guidelines for optimal ART 5 and for prophylaxis of opportunistic infection. 6 In addition to HIV and AIDS surveillance, the CDC is developing population-based studies to monitor the quality, use, and impact of care.
Increase adherence to therapy by individuals with HIV
Toxicity, poor adherence to HIV treatment regimens, and pharmacologic problems such as poor drug absorption can cause failure to achieve viral suppression and development of drug resistance. Patients' failure to adhere to the complicated dosage requirements of ART may be the most important reason for these negative outcomes of treatment. 47, 48 In addi tion, drug-resistant viruses can be transmitted to uninfected individuals. 49, 50 Improving ther apeutic adherence can reduce the frequency of drug resistance, but it will not eliminate it.
The CDC, in collaboration with other fed eral agencies, is conducting research on more effective interventions to increase adherence, including evaluating the feasibility of directly observed therapy. Directly observed therapy for tuberculosis has been feasible with simpler regimens of fixed duration, 51 but because ad herence toART regimens is so important, trials of directly observed therapy for HIV are needed even if treatment regimens remain complex and of long-term-possibly lifetime-duration. 5 
Increase the number of individuals with HIV who adopt and sustain HIV-STD risk reduction behavior
Many individuals with HIV feel healthier when undergoing ART than they did before such treatments became available. In addition, the impression that HIV is a treatable chronic disease, and that ART reduces infectiousness, may be leading to increases in risk behavior among HIV-infected individuals and those at highest risk for HIV infection. 52 In a number of cities in the United States, increasing rates of gonorrhea among men who have sex with men suggest that unsafe sexual behavior may be reemerging in this community. 53 While most individuals who learn that they are infected re duce their risk behavior, a considerable frac tion continue to have unprotected sex. 54 In a recent outbreak of primary and secondary syphilis in King County, Washington, among men who have sex with men, nearly three quar ters of whom were HIV infected. 55 In 1997, a National Institutes of Health consensus conference on HIV prevention in terventions called for increased research to identify interventions to support infected in dividuals in adopting and sustaining risk re duction behavior, 56 and several studies have been subsequently initiated by the National Institute of Mental Health and by the CDC. The CDC will strongly encourage health de partments, HIV prevention community plan ning groups, and community-based organiza tions to include people with HIV among priority populations for prevention programs. In addition, simple risk assessment tools are needed for physicians to assess the risk be havior of their HIV-infected patients and to provide referral for those needing prevention interventions. Preliminary information sug gests that even when they are enrolled in pri mary care, sexually active individuals with HIV are not receiving adequate HIV preven tion counseling or adequate diagnosis and treatment of other STDs. 57 The CDC is col laborating with the Infectious Diseases Soci ety of America and federal agencies to develop recommendations for prevention activities in care settings. With the vast majority of pre scriptions for ART being written by a few thousand physicians across the country, it is feasi ble to offer training to these caregivers to recognize ongoing risk behavior and refer peo ple appropriately for prevention services. Because many individuals with HIV are already in publicly financed systems of care, 46 the CDC will work closely with HCFA and HRSA to increase prevention services in those set tings. However, new resources are needed to increase the availability to all individuals with HIV infection of current prevention services, such as risk reduction counseling, peer group support, peer-based prevention case manage ment, STD treatment, substance abuse treat ment, and mental health services.
Some mathematical models suggest that much HIV transmission occurs from in dividuals who are recently infected and whose plasma viral loads are therefore high. 58 If preventing transmission from such individuals is essential for controlling the epidemic, partner counseling and referral services are crucial, because, in combina tion with serologic methods that detect re cently acquired HIV infection, they enable the identification of persons with early HIV infection. 59 Using such methods for rapid assessment of sexual or injection-drug-use networks can lead to the interruption of chains of active transmission by helping network members adopt and sustain risk re duction behavior.
Potential Impact and Resource Needs
The CDC has established the goal of re ducing new HIV infections in the United States by 50% in 4 years. 44 We estimate that to reach that goal, it is critical to increase by 30000 each year the number of infected people who be come aware of their serostatus and are linked to appropriate care and prevention services. In ad dition, full and appropriate prevention services must be provided for all individuals with HIV infection. These activities will require an addi tional public investment of $300 million per year. These additional resources would be di rected at (a) a highly targeted HIV counseling and testing effort to identify undiagnosed HIV seropositive persons, provide expanded volun tary testing, and develop and implement effec tive referrals to prevention and care services; (b) comprehensive HIV prevention services for each seropositive person whose ongoing be havior could lead to HIV transmission; and (c) HIV prevention services such as counseling for high-risk HIV-seronegative clients identi fied through the counseling and testing effort, particularly current partners of HIV-infected individuals. Increasing the number of individ uals with HIV who know their status will increase the number in care and will require increases in public financing for care through Medicaid and the Ryan White CARE Act.
Such an investment will save not only lives but money. Given that in 1997 each averted HIV infection saved society approxi mately $154000 in discounted lifetime treat ment costs of HIV disease, 60 an additional $300 million would have to avert only about 2000 HIV infections to produce these cost sav ings. Preliminary modeling analyses, based on literature on the effectiveness of behavioral intervention, suggest that SAFE programs might actually avert approximately 20% of HIV infections (8000 cases) per year (CDC, unpublished data, 2000). Thus, maintaining current prevention programs for high-risk un infected persons and fully implementing the CDC's SAFE initiative could reduce HIV in cidence by nearly 60% (approximately 23000 cases) and reduce the number of HIV-infected people with unknown serostatus by 80% in 4 years.
Partnerships
An important aspect of SAFE activities for those with HIV is developing new part nerships with organizations that historically have not been involved in HIV prevention and expanding traditional public health partners. The CDC has mobilized a public-private part nership, "X-AIDS ACT NOW! National Part nership Council," to fight the epidemic. More than 50 organizations, including medical care organizations, the pharmaceutical industry, private industry, and the media, as well as na tional and community-based HIV prevention organizations, make up the core of the part nership. These organizations are creating al liances that will motivate, coordinate, and di rect private sector resources to address the specific needs of SAFE.
Conclusion
Historically, HIV prevention programs have focused primarily on developing risk reduction interventions for those at high risk for becoming infected with HIV. In 1999, a review of 55 state and city applications to the CDC for funds for HIV prevention programs demonstrated that only 18 (32.7%) listed HIV-infected individuals as a priority popu lation for HIV prevention programs. Al though there are millions of people in the United States at "behavioral risk" for HIV infection, transmission can occur only from people who are infected with the virus. As the number of individuals with HIV contin ues to increase because of ART, so does the urgency for lifelong prevention strategies cus tomized for them. The 1996 International AIDS conference in Vancouver, British Co lumbia, marked the beginning of a new treat ment era in the AIDS epidemic, making knowledge of serostatus and linkage to pre vention and treatment services more impor tant than ever before. Atatimeofincreasingriskbehaviorinsome communities with high HIV prevalence and among an increasing number of individuals with HIV infection, SAFE strategies for HIV-infected persons represent a logical evolution of preven tion in an era of improved treatment. Such an ap proach couples a traditional infectious disease control focus on the infected person with behavioral interventions that have become standard elements in HIV prevention programs. In this new era, for individual as well as public health rea sons, every person infected with HIV should be voluntarilydiagnosed,evaluatedmedically,treated according to state-of-the-art guidelines, and pro vided with appropriate prevention services.
In combination with current programs focusing on HIV-negative individuals, SAFE offers an unprecedented opportunity for sig nificantly reducing HIV transmission and HIV-associated morbidity and mortality.
